This Viewpoint reviews how the recent US Supreme Court decision regarding affirmative action affects extant medical school admission policies seeking to enhance diversity of the national medical student body and its derivative national health care workforce.

This Viewpoint lists the top 3 pediatric drugs and product shortages, considers the federal government’s and manufacturers’ ethical duty to protect children, reviews the causes for the shortages, and suggests policy changes that could help fill in the gap.

This Viewpoint argues that the development of a distinctly improved generation of SARS-CoV-2 vaccines is paramount to offering a greater breadth and depth of protection for a longer duration against COVID-19 disease.

This Viewpoint discusses the growing role of medical students in shaping their own education and outlines the measures needed to ensure that medical student–directed learning remains aligned with the educational aims of the medical discipline.

This Viewpoint discusses the emergence of for-profit medical schools and the implications of the new business model for the physician workforce and the quality of medical education and practice.